Subscribe
Bonus: CNS Summit Call on the Impact of COVID-19 Crisis on Clinical Trials

CNS Summit Podcast

Bonus: CNS Summit Call on the Impact of COVID-19 Crisis on Clinical Trials

Featured Guest Speaker: Dr. Amy Abernethy, Deputy Commissioner and Acting CIO of the FDA
June 3, 2020
ADVERTISEMENT

Bonus: CNS Summit Call on the Impact of COVID-19 Crisis on Clinical Trials

This is a special episode of a webinar that was recorded on Friday, May 8, 2020.

In this recording, we hear from Dr. Amy Abernethy, Principal Deputy Commissioner and Acting CIO of the FDA, as she speaks with Dr Amir Kalali, Chief Curator of CNS Summit.

Drs. Abernethy and Kalali discuss:

  • How Covid-19 is impacting drug development
  • How the FDA is aligning and responding to the pandemic
  • Unexpected ways the pandemic may influence clinical research and medicine

For more podcasts like this, be sure to subscribe to the CNS Summit Podcast on Apple Podcasts, Google Podcasts or Spotify, and you can also find us on Health Podcast Network at HealthPodcastNetwork.com

Learn more about the CNS Summit and follow us on Twitter (@cnssummit) to find out more about upcoming events, news and announcements.

ADVERTISEMENT

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.